tiprankstipranks
Trending News
More News >
Community Health (CYH)
NYSE:CYH
US Market

Community Health (CYH) Earnings Dates, Call Summary & Reports

Compare
428 Followers

Earnings Data

Report Date
Apr 29, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
-0.08
Last Year’s EPS
-0.03
Same Quarter Last Year
Based on 7 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 18, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call communicates meaningful operational and financial progress — sequential margin expansion, improved cash flow and a clear deleveraging path supported by divestiture proceeds and targeted cost controls — along with ongoing strategic investments and technology/AI initiatives. However, there are notable near-term headwinds: modest volume softness, the revenue impact of multiple divestitures, exposure to lower ACA exchange enrollment (modeled as a $20M–$30M EBITDA headwind), rising medical specialist fees (5%–8% expected), and a ~$140M cash flow drag from an extra payroll period in 2026. On balance, the company has demonstrated positive momentum on margins, cash generation and balance-sheet repair while acknowledging manageable operational and market risks that have been incorporated into conservative 2026 guidance.
Company Guidance
CHS’s initial 2026 guidance calls for net revenue of $11.6–$12.0 billion, adjusted EBITDA of $1.34–$1.49 billion, cash flows from operations of $600–$700 million and capital expenditures of $350–$400 million; the company says this reflects roughly 4% core same‑site growth (after an estimated $20–$30 million EBITDA headwind from reduced HICS/enrollment), starts from a 2025 EBITDA baseline of about $1.36 billion, and excludes potential state‑directed payment and rural transformation benefits. The bridge subtracts divestiture impacts (about $30–$40 million of EBITDA from 2025‑completed sales and roughly $80–$90 million from the 2026 class; ~$210–$230 million of 2025 net revenue from early 2025 divestitures and ~ $1.0 billion net revenue reduction from 2026 announced/expected sales), and incorporates a ~$140 million 2026 cash headwind from an extra payroll period; Q4 2025 adjusted EBITDA was $395 million (12.7% margin), Q4 same‑store net revenue +2.1% and net revenue per adjusted admission +2.4%, Q4 medical specialist fees $169 million (5.4% of revenue, expected to grow 5–8% in 2026), FY25 cash flow from operations $543 million ($712 million adjusted excluding divestiture taxes) with adjusted free cash flow $150 million, year‑end 2025 leverage 6.6x (net debt $10.1 billion, expected to fall to ~ $9.2 billion after Huntsville), and no ABL draws with next major maturity in 2029.
Same-Store Revenue and Pricing Momentum
Same-store net revenue for Q4 increased 2.1% year-over-year, driven by a 2.4% increase in net revenue per adjusted admission.
Adjusted EBITDA and Margin Expansion
Q4 adjusted EBITDA was $395 million with a 12.7% margin; adjusted EBITDA was slightly up versus Q4 2024 on a same-store basis and the company achieved the midpoint of updated FY2025 guidance.
Improved Cash Flow and Free Cash Flow Positive
Cash flows from operations were $266 million in Q4 and $543 million for FY2025 (vs. $480 million in 2024). Excluding cash taxes on divestiture gains, adjusted cash flows from operations were $712 million and adjusted free cash flow was $150 million.
Leverage and Balance Sheet Progress
Net leverage improved from 7.4x at year-end 2024 to 6.6x at year-end 2025 and has been further reduced through early 2026 note redemptions; expected net debt after the Huntsville divestiture is ~ $9.2 billion (down from $10.1B YE2025 and $11.4B YE2024).
Material Divestiture Proceeds and Debt Reduction
Completed and pending divestitures generated significant cash (e.g., Clarksville ~ $623M gross, outreach labs ~$152M, contingent $91M) used to redeem high-coupon notes (two $223M redemptions at 103%) and reduce leverage.
Operational & Cost Control Improvements
Sequential adjusted EBITDA margin expansion, controlled labor (average hourly wage growth within expectations and flat contract labor), and 'live' expense down 110 bps YoY to 14.4% of net revenue in Q4 (down 50 bps for FY2025).
Strategic Investments and Service-Line Growth
Targeted market investments produced local wins: ER visits +13% in Knoxville over 2 years after ER expansion; Grandview births +20% (4,000+ babies) after $10M women's services investment; cardiac surgeries +16% in Longview; inbound transfers +~35% in Carlsbad.
Technology Transformation and Early AI Adoption
ERP implementation completed and reportedly saved ~ $50 million in the first year; AI use cases deployed or in rollout include appeals/autonomous coding, virtual patient sitters (reducing safety events), ambient documentation tools, and maternal-fetal early warning systems.

Community Health (CYH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CYH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 29, 2026
2026 (Q1)
-0.08 / -
-0.03
Feb 18, 2026
2025 (Q4)
-0.05 / -0.01
-0.4297.62% (+0.41)
Oct 23, 2025
2025 (Q3)
-0.25 / 1.27
-0.3523.33% (+1.57)
Jul 23, 2025
2025 (Q2)
-0.10 / -0.05
-0.1770.59% (+0.12)
Apr 23, 2025
2025 (Q1)
-0.08 / -0.03
-0.1478.57% (+0.11)
Feb 18, 2025
2024 (Q4)
0.08 / -0.42
-0.41-2.44% (-0.01)
Oct 23, 2024
2024 (Q3)
-0.21 / -0.30
-0.339.09% (+0.03)
Jul 24, 2024
2024 (Q2)
-0.14 / -0.17
-0.2222.73% (+0.05)
Apr 24, 2024
2024 (Q1)
-0.16 / -0.14
-0.4367.44% (+0.29)
Feb 20, 2024
2023 (Q4)
0.05 / -0.41
1.5-127.33% (-1.91)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CYH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 18, 2026
$3.34$3.52+5.39%
Oct 23, 2025
$3.26$4.10+25.77%
Jul 23, 2025
$3.88$2.90-25.26%
Apr 23, 2025
$2.43$2.88+18.52%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Community Health (CYH) report earnings?
Community Health (CYH) is schdueled to report earning on Apr 29, 2026, After Close (Confirmed).
    What is Community Health (CYH) earnings time?
    Community Health (CYH) earnings time is at Apr 29, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CYH EPS forecast?
          CYH EPS forecast for the fiscal quarter 2026 (Q1) is -0.08.

            Community Health (CYH) Earnings News

            CYH Surges on Q4 Beat
            Premium
            Market News
            CYH Surges on Q4 Beat
            3y ago